Johnson & Johnson Begins Phase Three COVID-19 Vaccine Trials
Johnson & Johnson Begins Phase Three COVID-19 Vaccine Trials

Dr. Paul Stoffels, chief scientific officer at Johnson & Johnson, joined Cheddar to discuss phase three COVID-19 vaccine trials.

More than 60,000 people worldwide have volunteered to be part of the study.